Experiencing difficulty walking is one of the most common mobility challenges faced by people living with MS. The good news is that there are things you can do — both with a physical therapist and by yourself, at home — that can make a real difference.
Joining me to discuss improving your gait, avoiding falls, and what experts are learning from the latest research in this area is the Director of Research for the Department of Health Care Sciences at Wayne State University School of Medicine, Dr. Nora Fritz.
We're also sharing the results of a study that looked at whether disease-modifying therapies had an impact on the number of hospitalizations or visits to the doctor someone with MS might experience over a 22-year period.
We'll tell you about a study that measured the outcome for people with relapsing-remitting MS who were treated with autologous hematopoietic stem cell transplantation (aHSCT) compared with the outcome for people with relapsing-remitting MS who were treated with Gilenya, Tysabri, or Ocrevus.
We'll share the results from a study that analyzed 56 other studies to determine the prevalence of sexual dysfunction among women living with MS.
We'll tell you about a nationwide study that's about to get underway that will try to answer the question, ‘Should people with MS over the age of 65 discontinue their disease-modifying therapy?‘
And we'll remind you about how you can join us in Napa Valley this Saturday, July 29th, for Crush MS.
We have a lot to talk about! Are you ready for RealTalk MS??!
This Week: Improving your balance and gait :22
A research team analyzed the risk of hospitalization over a 22-year period for people with MS who were on a disease-modifying therapy and compared those results to people with MS who weren't on a DMT 1:21
Researchers compared patient outcomes associated with autologous hematopoietic stem cell transplantation (aHSCT) and compared them with outcomes associated with Gilenya, Tysabri, and Ocrevus 4:40
A research team in Iran analyzed results from 56 separate studies about sexual dysfunction in women with MS 8:29
Should someone over the age of 65 discontinue their disease-modifying therapy? 11:40
Dr. Nora Fritz discusses gait, balance, fall prevention and more 15:20
Share this episode 33:49
I'll be at Crush MS! Will I see you there? 34:09
SHARE THIS EPISODE OF REALTALK MS
Just copy this link & paste it into your text or email: https://realtalkms.com/308
ADD YOUR VOICE TO THE CONVERSATION
I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts!
Phone: (310) 526-2283
And don't forget to join us in the RealTalk MS Facebook group!
STUDY: Disease-Modifying Drugs for Multiple Sclerosis and Subsequent Health Service Use
Tremlett's MS Research Explained: Disease-Modifying Drugs for Multiple Sclerosis and Subsequent Health Service Use
STUDY: Comparative Effectiveness of Autologous Hematopoietic Stem Cell Transplant vs Fingolimod, Natalizumab, and Ocrelizumab in Highly Active Relapsing-Remitting Multiple Sclerosis
STUDY: Prevalence and Risk of Developing Sexual Dysfunction in Women with Multiple Sclerosis (MS): A Systematic Review and Meta-Analysis
RealTalk MS Episode 255: Aging With MS with Dr. John Corboy
Join the RealTalk MS Facebook Group
Download the RealTalk MS App for iOS Devices
Download the RealTalk MS App for Android Devices
Give RealTalk MS a rating and review
RealTalk MS Episode 308
Guest: Dr. Nora Fritz